References
- de Olivera DE. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett 2007; 247: 182-96.
- Butel JS. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000; 21: 405-26.
- Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-100.
- Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999; 400: 464-8.
- Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2002; 2: 957-64.
- Eddy BE, Borman GS, Berkeley WH, Young RD. Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med 1961; 107: 191-7.
- Vilchez RA, Butel JS. Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev 2004; 17: 495-508.
- US NIH - NCI. Simian virus 40 and human cancer: questions and answers. http://www.cancer.gov/newscenter/sv40
- Shah KV. SV40 and human cancer: a review of recent data. Int J Cancer 2006; 120: 215-23.
- Leithner K, Leithner A, Clar H, Weinnaeusel A, Radl R, Krippl P, et al. Mesothelioma mortality in Europe: impact of asbestos consumption and Simian virus 40. Orph J Rare Dis 2006; 1: 44-55.
- Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa J, et al. Human mesothelial cells are unusually susceptible to Simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci USA 2000; 97: 10214-9.
- Bocchetta M, Eliasz S, Arakelian De Marco M, Rudzinski J, Zhang L, Carbone M. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res 2008; 68: 1022-9.
- Manfredi JJ, Dong J, Liu W, Resnick-Silverman L, Qiao R, Chahinian P, Saric M, et al. Evidence against a role for SV40 in human mesothelioma. Cancer Res 2005; 65: 2602-9.
- Carbone M, Pass HI, Miele L, Bocchetta M. New developments about the association of SV40 with human mesothelioma. Oncogene 2003; 22: 5173-80.
- Eržen J, Vidmar S, Sok M, Debeljak A, Kecelj P, Kovač V, et al. Surgical treatment of malignant pleural mesothelioma. Experience in the interdisciplinary approach in Slovenia. Radio Oncol 2005; 39: 123-31.
- Debevec M, Kovač V, Debeljak A, Eržen J, Remškar Z, Kern I. Maligni plevralni mezoteliom. Analiza bolnikov v Sloveniji 1980-1997. Zdrav Vestn 2000; 69: 599-606.
- Ćurin K, Šarić M, Strnad M. Incidence of malignant pleural mesothelioma in coastal and continental Croatia: epidemiological study. Croat Med J 2002; 43: 498-502.
- Churg A, Roggli V, Galateau-Salle F, Cagle P, Gibbs AR, Hasleton P, et al. Mesothelioma. In: Travis DW, Brambilla E, Muller-Hermelink HK, Harris CC, editors. WHO classification of tumours. Volume 10 - Pathology and genetics of tumours of the lung, pleura, thymus and heart. Geneva: WHO Press, 2004; p 128-36.
- McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996; 9: 1932-42.
- Kroczynska B, Curtone R, Bocchetta M, Yang H, Elmishad AG, Vacek P, et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and causing mesothelioma in hamsters. Proc Natl Acad Sci USA 2006; 103: 14128-33.
- Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJY, et al. Simian virus 40-like sequences in human mesothelioma. Oncogene 1994; 9: 1781-90.
- Engels EA, Viscidi RP, Galloway DA, Carter JJ, Cerhan JR, Davis S, et al. Case-control study of Simian virus 40 and non-Hodgkin lymphoma in the United States. J Nat Cancer Inst 2004; 96: 1368-74.
- Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, et al. A multi-institutional study confirms the presence and expression of Simian virus 40 in human malignant mesotheliomas. Cancer Res 1998; 58: 4505-9.
- Burmeister B, Schwerdtle T, Poser I, Hoffmann E, Hartwig A, Müller W-U, et al. Effects of asbestos initiation of DNA damage, induction of DNA-strand breaks, p53-expression and apoptosis in primary, SV40-transformed and malignant human mesothelial cells. Mutat Res 2004; 558: 81-92.
- Moens U, Van Ghelue M, Johannessen M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci 2007; 64: 1656-78.
- Ziegler A, Seemayer CA, Hinterberger M, Vogt P, Bigosch C, Gautschi O, et al. Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results. Lung Cancer 2007; 57: 282-91.
- Lednicky JA, Butel JS. Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. Dev Biol Stand 1998; 94: 155-64.